Health & Medicine

6
facebook twitter google print email
Media Contact:Evan Lerner | elerner@upenn.edu | 215-573-6604September 17, 2014

Penn Engineer Danielle Bassett Receives 2014 MacArthur Foundation Fellowship

blurb: 
Bassett will receive a five-year, $625,000, no-strings-attached grant. She is being recognized for her research that uses network science to better understand on how the brain can learn and adapt.

The John D. and Catherine T. MacArthur Foundation announced Wednesday that the University of Pennsylvania’s Danielle S. Bassett has been selected as a 2014 MacArthur Fellow.

Advances in Biology and the Web Are Radically Altering Cancer Trials

September 15, 2014

Amy Clark, Robert Vonderheide, Angela DeMichele and Martha Sweeney of the Perelman School of Medicine are quoted about new advances for cancer clinical trials.

Article Source: Philadelphia Inquirer

Fears Rise of Medication Misuse by the Elderly

September 14, 2014

David Oslin of the Perelman School of Medicine says the misuse of medications “is a rising problem in seniors as the baby-boom generation ages.”

Article Source: Wall Street Journal
facebook twitter google print email
Media Contact:Karen Kreeger | Karen.kreeger@uphs.upenn.edu | 215-349-5658September 11, 2014

Penn Medicine: Zebrafish Model of a Learning and Memory Disorder Shows Better Way to Target Treatment

Using a zebrafish model of a human genetic disease called neurofibromatosis (NF1), a team from the Perelman School of Medicine at the University of Pennsylvania has found that the learning and memory components of the disorder are distinct features that will likely need different treatment approaches.

facebook twitter google print email
Media Contact:Greg Richter | gregory.richter@uphs.upenn.edu | 215-614-1937September 11, 2014

Penn Medicine Study Reveals Profile of Patients Most Likely to Delay Hospice Enrollment Until Final Days of Life

One in six cancer patients enroll in hospice only during their last three days of life, according to a new study from a team from the Perelman School of Medicine at the University of Pennsylvania.

facebook twitter google print email
Media Contact:Holly Auer | holly.auer@uphs.upenn.edu | 215-349-5659September 11, 2014

Center for Advanced Cellular Therapeutics to Rise on Penn Medicine Campus

The University of Pennsylvania today reached an important milestone in its alliance with Novartis as it unveiled plans for the construction of a first-of-its-kind Center for Advanced Cellular Therapeutics (CACT) on the Penn Medicine campus in Philadelphia.

facebook twitter google print email
Media Contact:Greg Richter | gregory.richter@uphs.upenn.edu | 215-614-1937September 11, 2014

Penn Medicine Study Reveals Profile of Patients Most Likely to Delay Hospice Enrollment Until Final Days of Life

One in six cancer patients enroll in hospice only during their last three days of life, according to a new study from a team from the Perelman School of Medicine at the University of Pennsylvania.

facebook twitter google print email
Media Contact:Karen Kreeger | Karen.kreeger@uphs.upenn.edu | 215-349-5658September 9, 2014

Penn Researcher and CVS Health Physician Urge New Payment Model for Costly Gene Therapy Treatments

Hoping to encourage sufficient investments by pharmaceutical companies in expensive gene therapies, which often consist of a single treatment, a Penn researcher and the chief medical officer of CVS Health outline an alternative payment model in this month’s issue of Nature Biotechnology.

facebook twitter google print email
Media Contact:Karen Kreeger | Karen.kreeger@uphs.upenn.edu | 215-349-5658September 8, 2014

Penn Team Finds Ovarian Cancer Oncogene in 'Junk DNA'

Over the years researchers have made tremendous strides in the understanding and treatment of cancer by searching genomes for links between genetic alterations and disease.

Study of Jewish Women Shows Link to Cancer Without Family History

September 4, 2014

Susan Domchek of the Perelman School of Medicine says that the study does not “resolve the question of what the risk is to someone with no family history and a mutation.”

Article Source: New York Times